14 articles for P Lopez
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
An Orally Available BACE1 Inhibitor That Affords Robust CNS Aß Reduction without Cardiovascular Liabilities.

Amgen
Development of 2-aminooxazoline 3-azaxanthenes as orally efficaciousß-secretase inhibitors for the potential treatment of Alzheimer's disease.

Amgen
Discovery of a potent, dual serotonin and norepinephrine reuptake inhibitor.

Eli Lilly
Design and synthesis of potent, orally efficacious hydroxyethylamine derivedß-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors.

Amgen
Design and preparation of a potent series of hydroxyethylamine containingß-secretase inhibitors that demonstrate robust reduction of centralß-amyloid.

Amgen
A Potent and Orally Efficacious, Hydroxyethylamine-Based Inhibitor of ß-Secretase.

TBA
From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1).

Amgen
Discovery of a Covalent Inhibitor of KRAS

TBA
3-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS

Mindset Pharma
Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenase

Idorsia Pharmaceuticals
Heterocyclic derivative and pharmaceutical composition comprising the same

Shionogi
Synthesis of Novel Hybrids Inspired from Bromopyrrole Alkaloids Inhibiting MMP-2 and -12 as Antineoplastic Agents.

University of Kwazulu-Nata
3-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof

Targacept
Interactive binding between the substrate and allosteric sites of carbamoyl-phosphate synthetase.

Pennsylvania State University